IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $76,661,488 | 13.08% |
| MPM BioImpact LLC | 2,149,550 | $13,735,625 | 3.56% |
| Ghost Tree Capital, LLC | 1,300,000 | $8,307,000 | 3.55% |
| Finepoint Capital LP | 1,545,589 | $9,876 | 3.19% |
| Perceptive Advisors | 9,971,780 | $63,719,674 | 1.79% |
| Affinity Asset Advisors, LLC | 375,000 | $2,396,250 | 0.94% |
| Long Focus Capital Management, LLC | 2,061,814 | $13,174,991 | 0.91% |
| Avoro Capital Advisors LLC | 7,020,000 | $44,857,800 | 0.67% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,822,080 | $11,643,091 | 0.67% |
| Parametrica Management Ltd | 47,900 | $305,602 | 0.63% |
| ACUTA CAPITAL PARTNERS, LLC | 153,639 | $981,753 | 0.60% |
| Rhenman & Partners Asset Management AB | 864,378 | $5,523,375 | 0.58% |
| 683 Capital Management, LLC | 1,000,000 | $6,390,000 | 0.54% |
| Boxer Capital, LLC | 1,505,133 | $9,617,800 | 0.51% |
| Vivo Capital, LLC | 655,057 | $4,186 | 0.48% |
| Aristotle Atlantic Partners, LLC | 1,008,436 | $6,443,906 | 0.36% |
| SEVEN EIGHT CAPITAL, LP | 210,400 | $1,344,456 | 0.35% |
| Orbimed Advisors | 2,007,458 | $12,827,657 | 0.24% |
| Nikko Asset Management Americas, Inc. | 2,587,618 | $16,509,003 | 0.24% |
| QVT Financial LP | 678,564 | $4,336,024 | 0.23% |
External links
This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q4 2022. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.